ÂÜÀòÂÒÂ×

Bill Fairey is a biopharmaceutical executive who excels at creating value around scientific discovery, particularly in the treatment of rare/orphan diseases. A strategic leader with broad commercial, medical, and P&L expertise, Bill has significant experience building strong and scalable commercial entities that open global markets and launch novel therapeutics. He has played key roles in transforming young biopharmaceutical companies from R&D to RD&C and was involved in guiding MyoKardia and Actelion to profitable exits. Frequently the first commercial executive in a scientific organization, Bill has a reputation for attracting high-quality talent, with a focus on diversity, inclusion, and a can-do approach to science and growth.